XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Total net sales $ 2,958,387 $ 2,956,416 $ 2,971,956
Costs and operating expenses:      
Costs and operating expenses 1,200,201 1,195,223  
Selling and administrative expenses 690,148 736,014 658,026
Research and development expenses 183,027 174,945 176,190
Purchased intangibles amortization 47,090 32,558 6,366
Litigation provisions 11,568 0 0
Acquired in-process research and development 0 0 9,797
Total costs and operating expenses 2,132,034 2,138,740 2,098,561
Operating income 826,353 817,676 873,395
Other income, net 776 807 2,228
Interest expense (89,677) (98,861) (48,797)
Interest income 17,416 16,621 11,020
Income before income taxes 754,868 736,243 837,846
Provision for income taxes 117,034 94,009 130,091
Net income $ 637,834 $ 642,234 $ 707,755
Net income per basic common share $ 10.75 $ 10.87 $ 11.8
Weighted-average number of basic common shares 59,333 59,076 59,985
Net income per diluted common share $ 10.71 $ 10.84 $ 11.73
Weighted-average number of diluted common shares and equivalents 59,552 59,270 60,331
Product [Member]      
Revenues:      
Total net sales $ 1,844,176 $ 1,903,050 $ 1,988,169
Costs and operating expenses:      
Costs and operating expenses 747,920 766,374 836,209
Service [Member]      
Revenues:      
Total net sales 1,114,211 1,053,366 983,787
Costs and operating expenses:      
Costs and operating expenses $ 452,281 $ 428,849 $ 411,973